Quick Takeaways
- Raymond Prudo-Chlebosz filed SCHEDULE 13D/A for Akari Therapeutics Plc Ordinary Shares, $0.000000005 par value (AKTX).
- Disclosed ownership: 8.9%.
- Date of event: 02 Mar 2026.
Raymond Prudo-Chlebosz - 02 Mar 2026 SCHEDULE 13D/A Report for Akari Therapeutics Plc Ordinary Shares, $0.000000005 par value (AKTX)
- Filing Manager
- Raymond Prudo-Chlebosz
- Reporting Manager
- Ray Prudo, M.D.
- Symbol
- AKTX
- Shares outstanding
- 94,284,567,045 shares
- Disclosed Ownership
- 8,391,326,467 shares
- Ownership
- 8.9%
- Form type
- SCHEDULE 13D/A
- Filing time
- 04 Mar 2026, 16:52:44 UTC
- Date of event
- 02 Mar 2026
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Raymond Prudo-Chlebosz disclosed 8.9% ownership in Akari Therapeutics Plc Ordinary Shares, $0.000000005 par value (AKTX) on 02 Mar 2026."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 04 Mar 2026, 16:52.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ray Prudo, M.D. | 8.9% | 8,391,326,467 | 7,551,850,267 | 839,476,200 | /s/ Ray Prudo, M.D. | Ray Prudo, Reporting Person | 0001653262 |
| RPC Pharma Limited | 0.87% | 800,766,600 | 0 | 800,766,600 | /s/ Ray Prudo, M.D. | Ray Prudo, Reporting Person | |
| Praxis Trustees Limited as trustee of the Sonic Healthcare Holding Company | 0.04% | 38,709,600 | 0 | 38,709,600 | /s/ Jodie Travers | Director for and on behalf of Praxis Trustees Limited |